Explore more publications!
Africa News Ledger
Got News to Share?

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 12, 2026

Space Force Association Announces 2025 Spacepower Excellence Awards Recipients
January 12, 2026

Space Force Association Announces 2025 Spacepower Excellence Awards Recipients

Indeterminate EIN Presswire
GWM Unveils Global Technology Investment White Paper at CES 2026, Anchoring 'User Value' as the Core of Innovation
January 12, 2026

GWM Unveils Global Technology Investment White Paper at CES 2026, Anchoring 'User Value' as the Core of Innovation

Indeterminate EIN Presswire
Brunswick Announces Inferred Mineral Resource of 52.2 Mt Grading 1.08% Li2O on Globex’s 3% GMR Royalty Claims
January 12, 2026

Brunswick Announces Inferred Mineral Resource of 52.2 Mt Grading 1.08% Li2O on Globex’s 3% GMR Royalty Claims

Indeterminate GlobeNewswire
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026

VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
January 12, 2026

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

Indeterminate GlobeNewswire
BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk
January 12, 2026

BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk

Indeterminate GlobeNewswire
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
January 12, 2026

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Indeterminate GlobeNewswire
Latin Metals Positions for a Catalyst-Driven 2026 with Gold and Copper Exposure
January 12, 2026

Latin Metals Positions for a Catalyst-Driven 2026 with Gold and Copper Exposure

Indeterminate GlobeNewswire
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
January 12, 2026

Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting

Indeterminate GlobeNewswire
Kailera Therapeutics Announces First Participants Randomized in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide (KAI-9531)
January 12, 2026

Kailera Therapeutics Announces First Participants Randomized in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide (KAI-9531)

Indeterminate GlobeNewswire
CRITICAL METALS CORP NASDAQ-CRML Acquires an Integrated Rare Earth Element Assay Analysis Lab Facility to Support Faster Drilling Assay Results for 2026 Drilling Campaign at Tanbreez
January 12, 2026

CRITICAL METALS CORP NASDAQ-CRML Acquires an Integrated Rare Earth Element Assay Analysis Lab Facility to Support Faster Drilling Assay Results for 2026 Drilling Campaign at Tanbreez

Indeterminate GlobeNewswire
Integral Metals Provides 2025 Year-in-Review and Outlines 2026 Exploration Plans
January 12, 2026

Integral Metals Provides 2025 Year-in-Review and Outlines 2026 Exploration Plans

Indeterminate GlobeNewswire
Cabaletta Bio Announces 2026 Strategic Priorities
January 12, 2026

Cabaletta Bio Announces 2026 Strategic Priorities

Indeterminate GlobeNewswire
Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio
January 12, 2026

Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio

Indeterminate GlobeNewswire
Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference
January 12, 2026

Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones
January 12, 2026

Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones

Indeterminate GlobeNewswire
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
January 12, 2026

Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress

Indeterminate GlobeNewswire
Mereo BioPharma Provides Corporate Update
January 12, 2026

Mereo BioPharma Provides Corporate Update

Indeterminate GlobeNewswire
Copper Quest and i2i Enter Into Corporate Marketing and Investor Awareness Agreement
January 12, 2026

Copper Quest and i2i Enter Into Corporate Marketing and Investor Awareness Agreement

Indeterminate GlobeNewswire
Osisko Metals Announces C$15 Million "Bought Deal" Flow-Through Share Financing
January 12, 2026

Osisko Metals Announces C$15 Million "Bought Deal" Flow-Through Share Financing

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions